9110 Katy Freeway,
Houston,
TX
77055
-
About the Provider
-
Education & Board Certification
-
Professional Associations
Swetha Yadav, MD, MPH, completed her medical degree at Bangalore Medical College and Research Institute in India in 2000. She then relocated to earn a Master of Public Health at the University of Alabama School of Medicine at Birmingham (UAB) in 2004. After completing her internship at John H. Stroger Hospital of Cook County in Chicago in 2006, Dr. Yadav returned to Alabama, completing an Internal Medicine residency at University of Alabama School of Medicine at Montgomery in 2008. She also completed a Hematology and Oncology fellowship at UAB in 2012. Dr. Yadav joined Kelsey-Seybold in February 2025.
Dr. Yadav was inspired to pursue Hematology and Oncology by her attending physician, Dr. Rosalind Catchatourian, during her internship. As a board-certified hematologist and oncologist, Dr. Yadav diagnoses and treats a variety of cancers, including blood, tissue, and organ cancers. Her favorite aspect of practicing medicine is having the opportunity to support and help patients every day.
Dr. Yadav understands that listening to her patients, being available, and following evidence-based guidelines enable her to provide the best possible and most comprehensive care.
Hobbies and Interests
In her free time, Dr. Yadav enjoys hiking and spending time with family.
Awards & Publications
Awards
- Tinsley Harrison Resident of the year award 2007-2008 in recognition of outstanding achievements in teaching skills, academics, and professionalism.
Publications
Turner-Henson, A., Sathiakumar, N., Yadav, S.S., Kohler, C., Grad, R. & Schoenberger, Y.M. (2005). American Journal of Respiratory and Critical Care (abstract). Reducing secondhand smoke exposure among young children: Maternal smoking practices and household restrictions.
Swetha S Yadav, Carolyn Brecklin, Asymmetric Dimethylarginine: The missing link between Chronic Kidney Disease and Cardiovascular Mortality? Kidney, a current survey of world literature 2007; 16:4-7.
Morphoproteomics confirms the mTORC2 Pathway as a Resistance Signature and Activated ERK and STAT3 Prosurvival/Antiapoptotic Pathways in Metastatic Renal Cell Carcinoma Progressing on Rapalogs. Swetha Yadav, M.D., Jamie Buryanek, M.D. Robert E. Brown, M.D., Fangqian Ouyang, Robert Amato, D.O Journal of Clinical Oncology 31, 2013. (suppl; abstr e15548)
Morphoproteomics of VEGF pathway mediators as evidence of reversible resistance to VEGF-TKIs demonstrated by expression of activated ERK and STAT3 in Metastatic renal cell carcinoma (mRCC). Shan Guo, Swetha Siddappa Yadav, Jamie Buryanek, Robert E Brown, Fangqian Ouyang, Robert J. Amato; The University of Texas Health Science Center at Houston, Houston, TX; University of Texas Health Science Center Medical School, Houston, TX Journal of Clinical Oncology 31, 2013. (suppl; abstr e15552)
Research
- Investigating the role of MicroRNA 15 and 16 and their role in CLL.
- FCRL2 regulation by MicroRNA 15 and 16.
- Methods involve MicroRNA isolation from human lymphocytes and the use of Real Time PCR.
- Assessment of a direct correlation between MicroRNA 15/16 and FCRL2 expression by using electroporation.
MicroRNA and their role in CLL as potential therapeutic targets and prognostic factor in the Department of Biomedical Research at the University of Alabama at Birmingham.
Education
- Bangalore Medical College and Research Institute (BMCRI) – Bangalore, India, 2000
Internship/Residency
- Internal Medicine residency: University of Alabama School of Medicine – Montgomery, AL 2008; Hematology and Oncology fellowship: University of Alabama School of Medicine – Birmingham, AL, 2012
Board Certifications
- American Board of Internal Medicine - Hematology
- American Board of Internal Medicine - Medical Oncology
Locations
North Houston Campus
15655 Cypress Woods Medical Drive,
Houston,
TX
77014